Meningococcal Conjugate Quadrivalent Vaccine single Dose vial Meningococcal Conjugate Quardrivalent vaccine single dose Vial Quardrivalent meningococcal conjugate vaccines conjugate with diphtheria toxoid or a non-toxic mutant of Diphtheria toxin (CR

• Country: Sri Lanka
• Summary: Meningococcal Conjugate Quadrivalent Vaccine single Dose vial Meningococcal Conjugate Quardrivalent vaccine single dose Vial Quardrivalent meningococcal conjugate vaccines conjugate with diphtheria toxoid or a non-toxic mutant of Diphtheria toxin (CR
• LKT Ref No: 116243128
• Deadline: 24 Apr 2025
• Financier: Self Financed
• Purchaser Ownership: Public
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: DHS/P/WW/300/26
• Purchaser's Detail:

Purchaser : STATE PHARMACEUTICALS CORPORATION OF SRI LANKA
No.75, Sir Baron Jayathilake Mawatha, Colombo 01, Sri Lanka. Telephone :+94 (0)11 2320356-9, Fax :+94 (0)11 2447118
Email :chairman@spc.lk

• Description:
• Meningococcal Conjugate Quadrivalent Vaccine single Dose vial Meningococcal Conjugate Quardrivalent vaccine single dose Vial Quardrivalent meningococcal conjugate vaccines conjugate with diphtheria toxoid or a non-toxic mutant of Diphtheria toxin (CRM 197) or Tetanus toxoid, each 0.5mL reconstituted single dose vaccine to be used as deep intramuscular injection. Quardrivalent (A, C, W135, Y) meningococcal conjugate vaccines using Diphtheria toxoid as carrier protein (A, C, W 135, Y -D) which contains 4 mcg of each of the serogroup polysaccharides, which are individually conjugated to the carrier, or quardrivalent vaccine,conjugated to CRM-197 (A, C, W135, Y-CRM),which contains 10microgram of polysaccharide A and 5microgram of each of the polysaccharides C,W135 and Y, which are individually conjugated to the carrier with no adjutants or preservatives in single dose formulations. Suitable diluents to be supplied with the vaccine.
• Documents:

 Tender Notice